KOMET: An unblinded, randomised, two parallelgroup, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy

Eugen Trinka, Anthony G. Marson, Wim Van Paesschen, Reetta Kälviäinen, Jacqueline Marovac, Benjamin Duncan, Sonja Buyle, Yngve Hallström, Petr Hon, Gian Carlo Muscas, Mark Newton, Heinz Joachim Meencke, Philip E. Smith, Bernd Pohlmann-Eden

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

106 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'KOMET: An unblinded, randomised, two parallelgroup, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy'. En conjunto forman una huella única.

Medicine & Life Sciences